Acrux Limited

ACR.AX·ASX·Healthcare

Compare

0.0110−0.0010 (−8.33%)today

At close: Oct 19, 11:32 AM AEDT · May be delayed up to 20 min · AUD

Key statistics

Previous close0.0120

Open0.0110

Day range—

52-week range0.00900.0210

Off day high0.00%

Off 52-week high−47.62%

Volume330.72K

Avg. volume (3M)930.12K

Market cap6.73M

EPS (TTM)0.000000

Forward P/E—

P/E ratio (TTM)—

Dividend yield—

Beta (5Y)1.02

Shares outstanding611.65M

Short interest—

Earnings date—

Analyst target—

Profit margin−9.18%

Against its peers

Compare in full ›

	ACR.AX	FBIO	ACXP	CANF	DARE	VTGN
Market cap	6.73M	62.37M	6.12M	5.34M	14.25M	8.88M
P/E (TTM)	—	0.7	—	—	—	—
Forward P/E	—	-1.1	-0.6	-1.9	-1.7	-0.1
Price/book	3.7	0.4	0.6	0.8	-19.6	0.4
Dividend yield	—	—	—	—	—	—
1-year change	−7.69%	−32.25%	−84.22%	−83.08%	−64.63%	−95.54%
Today	−8.33%	−2.09%	−5.98%	−4.86%	−2.08%	−6.10%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Related companies

Compare ›

The businesses closest to ACR.AX's by what they do, from their descriptions, with the same industry weighted in.

Company	Mkt cap	Price	Today
Fortress Biotech, Inc.FBIO · Biotechnology	62.37M	1.8700	−2.09%
Acurx Pharmaceuticals, Inc.ACXP · Biotechnology	6.12M	1.1000	−5.98%
Can-Fite BioPharma Ltd.CANF · Biotechnology	5.34M	1.7600	−4.86%
Daré Bioscience, Inc.DARE · Biotechnology	14.25M	0.7246	−2.08%
Vistagen Therapeutics, Inc.VTGN · Biotechnology	8.88M	0.2000	−6.10%
Impact BioMedical Inc.IBO · Biotechnology	22.90M	2.6800	−15.15%
BioLineRx Ltd.BLRX · Biotechnology	10.01M	2.0100	−1.95%
Azitra, Inc.AZTR · Biotechnology	4.33M	0.0715	0.00%

What visitors to ACR.AX's page also look at.

Company	Mkt cap	Price	Today
STARPHARMA FPO [SPL]SPL.AX	359.80M	0.7500	0.00%
AUCLINICAL FPO [ACL]ACL.AX	533.44M	2.8600	+0.70%
AINSWORTH FPO [AGI]AGI.AX	382.26M	1.1350	0.00%
AUSTIN ENG FPO [ANG]ANG.AX	87.24M	0.1400	0.00%
ACTINOGEN FPO [ACW]ACW.AX	178.21M	0.0460	+2.22%

From the 4Conservative instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All ACR.AX news ›

Seeking Alpha·Oct 12Positive

Acrux Limited (ARUXF) Shareholder/Analyst Call Transcript

Acrux Limited (ARUXF) Shareholder/Analyst Call October 12, 2026 12:00 AM EDT John Warmbrunn - MD, CEO & DirectorJolanta Airey - Chief Medical OfficerFelicia Colagrande - Product Development & Technical Affairs Director Welcome to the Acrux…

Grafa·Oct 11Positive

Acrux secures FDA Phase 3 pathway approval

Assets related to this article Acrux (ASX:ACR) has secured a confirmed Phase 3 regulatory pathway from the U.S. Food and Drug Administration for its female testosterone metered-dose transdermal spray targeting hypoactive sexual desire…

TradingView·Oct 11

Acrux Ltd Says FDA Clears Regulatory Pathway For Female Testosterone Mdts

TradingView Acrux Ltd Says FDA Clears Regulatory Pathway For Female Testosterone Mdts

From articles in the 4Search news index.

In the news

3mentions in 30 days

3with it in the headline

Positivesentiment

Most coverage from

grafa.com1
seekingalpha.com1
tradingview.com1

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

About

Profile ›

Acrux Limited, together with its subsidiaries, develops and commercializes topically applied pharmaceutical products in Australia, the United States, Europe, and internationally. The company offers Dapsone 7.5% and 5% gels for the treatment of acne vulgaris; Nitroglycerine 0.4% ointments for the treatment of moderate to severe pain associated with chronic anal fissure; Lidocaine and Prilocaine creams USP 2.5% for local analgesia and pre-treatment for infiltration anesthesia; and estradiol transdermal sprays for wom…

SectorHealthcare

IndustryBiotechnology

Chief executiveJohn Warmbrunn

HeadquartersWest Melbourne, VIC, Australia

Websiteacrux.com.au

Quarterly results

Financials ›

Revenue
Net income

Prices may be delayed up to 15 min. Not investment advice.

Track record

Leaderboard ›

Days on the list	30 d	1 yr	Best
Trending	0	0	—

Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).

Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).

Not eligible for Growth tech (U.S. technology stocks only).

Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).

A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.